188 related articles for article (PubMed ID: 30943984)
1. Increase expression of CD177 in Kawasaki disease.
Huang YH; Lo MH; Cai XY; Liu SF; Kuo HC
Pediatr Rheumatol Online J; 2019 Apr; 17(1):13. PubMed ID: 30943984
[TBL] [Abstract][Full Text] [Related]
2. Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array.
Kuo HC; Chang JC; Kuo HC; Yu HR; Wang CL; Lee CP; Huang LT; Yang KD
Arthritis Rheumatol; 2015 Mar; 67(3):828-36. PubMed ID: 25470559
[TBL] [Abstract][Full Text] [Related]
3. Decreased DNA methyltransferases expression is associated with coronary artery lesion formation in Kawasaki disease.
Huang YH; Chen KD; Lo MH; Cai XY; Chang LS; Kuo YH; Huang WD; Kuo HC
Int J Med Sci; 2019; 16(4):576-582. PubMed ID: 31171909
[No Abstract] [Full Text] [Related]
4. Identifying genetic hypomethylation and upregulation of Toll-like receptors in Kawasaki disease.
Huang YH; Li SC; Huang LH; Chen PC; Lin YY; Lin CC; Kuo HC
Oncotarget; 2017 Feb; 8(7):11249-11258. PubMed ID: 28061462
[TBL] [Abstract][Full Text] [Related]
5. [Biomarkers associated with unresponsiveness to IVIG in children with Kawasaki disease].
Abe J; Matsuda A
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(1):27-34. PubMed ID: 23445729
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease.
Kuo HC; Li SC; Huang LH; Huang YH
Oncotarget; 2017 Sep; 8(37):60875-60891. PubMed ID: 28977831
[TBL] [Abstract][Full Text] [Related]
7. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
Chang LS; Lo MH; Li SC; Yang MY; Hsieh KS; Kuo HC
Oncotarget; 2017 Jan; 8(2):2044-2052. PubMed ID: 27893416
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic hypomethylation and upregulation of NLRC4 and NLRP12 in Kawasaki disease.
Huang YH; Lo MH; Cai XY; Kuo HC
Oncotarget; 2018 Apr; 9(27):18939-18948. PubMed ID: 29721174
[TBL] [Abstract][Full Text] [Related]
9. HAMP promoter hypomethylation and increased hepcidin levels as biomarkers for Kawasaki disease.
Huang YH; Kuo HC; Li SC; Cai XY; Liu SF; Kuo HC
J Mol Cell Cardiol; 2018 Apr; 117():82-87. PubMed ID: 29501389
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide transcriptome analysis to further understand neutrophil activation and lncRNA transcript profiles in Kawasaki disease.
Ko TM; Chang JS; Chen SP; Liu YM; Chang CJ; Tsai FJ; Lee YC; Chen CH; Chen YT; Wu JY
Sci Rep; 2019 Jan; 9(1):328. PubMed ID: 30674924
[TBL] [Abstract][Full Text] [Related]
11. FCN1 (M-ficolin), which directly associates with immunoglobulin G1, is a molecular target of intravenous immunoglobulin therapy for Kawasaki disease.
Okuzaki D; Ota K; Takatsuki SI; Akiyoshi Y; Naoi K; Yabuta N; Saji T; Nojima H
Sci Rep; 2017 Sep; 7(1):11334. PubMed ID: 28900133
[TBL] [Abstract][Full Text] [Related]
12. Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease.
Abe J; Ebata R; Jibiki T; Yasukawa K; Saito H; Terai M
J Allergy Clin Immunol; 2008 Nov; 122(5):1008-1013.e8. PubMed ID: 18930517
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of TLR2, 3, 9 and Signaling Mediators, MyD88 and TRIF, Gene Transcript Levels in Patients with Kawasaki Disease Treated with IVIG.
Mortazavi SH; Amin R; Alyasin S; Kashef S; Karimi MH; Babaei M; Younesi V
Iran J Allergy Asthma Immunol; 2015 Apr; 14(2):188-97. PubMed ID: 25780885
[TBL] [Abstract][Full Text] [Related]
14. Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease.
Kuo KC; Yang YL; Lo MH; Cai XY; Guo MM; Kuo HC; Huang YH
Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829381
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of granulopoiesis related genes in neutrophil subsets distinguished by membrane expression of CD177.
Hu N; Mora-Jensen H; Theilgaard-Mönch K; Doornbos-van der Meer B; Huitema MG; Stegeman CA; Heeringa P; Kallenberg CG; Westra J
PLoS One; 2014; 9(6):e99671. PubMed ID: 24926686
[TBL] [Abstract][Full Text] [Related]
16. Identification of CD177 as the most dysregulated parameter in a microarray study of purified neutrophils from septic shock patients.
Demaret J; Venet F; Plassais J; Cazalis MA; Vallin H; Friggeri A; Lepape A; Rimmelé T; Textoris J; Monneret G
Immunol Lett; 2016 Oct; 178():122-30. PubMed ID: 27568821
[TBL] [Abstract][Full Text] [Related]
17. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
Chantasiriwan N; Silvilairat S; Makonkawkeyoon K; Pongprot Y; Sittiwangkul R
Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
[TBL] [Abstract][Full Text] [Related]
18. Identification of increased expression of activating Fc receptors and novel findings regarding distinct IgE and IgM receptors in Kawasaki disease.
Chang LS; Ming-Huey Guo M; Lo MH; Kuo HC
Pediatr Res; 2021 Jan; 89(1):191-197. PubMed ID: 31816620
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation by infliximab therapy in Kawasaki disease patients with immunoglobulin resistance.
Ogihara Y; Ogata S; Nomoto K; Ebato T; Sato K; Kokubo K; Kobayashi H; Ishii M
Pediatr Res; 2014 Sep; 76(3):287-93. PubMed ID: 24964229
[TBL] [Abstract][Full Text] [Related]
20. CD177
Zhou G; Yu L; Fang L; Yang W; Yu T; Miao Y; Chen M; Wu K; Chen F; Cong Y; Liu Z
Gut; 2018 Jun; 67(6):1052-1063. PubMed ID: 28468761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
